DUBLIN–(BUSINESS WIRE)–The “Transplant Diagnostics Market – Global Outlook and Forecast 2020-2025” report has been added to ResearchAndMarkets.com’s offering.
The global transplant diagnostics market is expected to grow at a CAGR of over 6% during the forecast period 2019-2025.
The following factors are likely to contribute to the growth of the transplant diagnostics market during the forecast period:
- Growing Number of Transplantations & Prevalence of Chronic Diseases
- Increasing Shift from Serological to Molecular Diagnostic Testing in Transplant Patients
- Emergence of cfDNA in Transplant Diagnostics
- Increasing Focus on Identifying New Biomarkers for Minimizing Transplantation Rejection
The global transplant diagnostics market is growing at a steady rate, which is expected to continue during the forecast period. The high demand for molecular diagnostic tests and the availability of technologically advanced devices with favorable patient demographics are mainly contributing to the high demand for transplant diagnostics devices. Ongoing technological advancements and innovations witnessed in the development of new genomic, transcriptomic, and proteomic biomarkers, especially in the molecular segment, can provide personalized management for transplantation and can detect rejection episodes and infections early, thereby improving the patient outcomes and success rate.
The study considers the present scenario of the global transplant diagnostics market and its market dynamics for the period 2019-2025. It covers a detailed overview of several market growth enablers, restraints, and trends. The study offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent companies operating in the market.
Key Market Insights
- Offers sizing and growth prospects of the transplant diagnostics market for the forecast period 2019-2024.
- Provides comprehensive insights on the latest industry trends, forecast, and growth drivers in the market.
- Includes a detailed analysis of growth drivers, challenges, and investment opportunities.
- Delivers a complete overview of segments and the regional outlook of the transplant diagnostics market.
- Offers an exhaustive summary of the vendor landscape, competitive analysis, and key strategies to gain a competitive advantage.
Key Topics Covered:
1 Research Methodology
2 Research Objectives
3 Research Process
4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.2 Base Year
4.3 Scope of the study
4.4 Market Segments
5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 Market at a Glance
7 Introduction
7.1 Transplant Diagnostics: Overview
7.1.1 Background
7.1.2 Role of Diagnostics in Transplantations
8 Market Dynamics
8.1 Market Growth Enablers
8.1.1 Increasing Number of Transplantations & Prevalence of Chronic Diseases
8.1.2 Rising Incidence of Infections Caused by Transplantations
8.1.3 Increasing Shift from Serological to Molecular Diagnostic Testing in Transplant Patients
8.1.4 Technological Advancements in Transplant Diagnostics
8.2 Market Growth Restraints
8.2.1 Increasing Gap Between Number of Organ Donors & Recipients
8.2.2 Ethical Challenges Related to Organ Procurement and Transplantation
8.2.3 High Costs Associated with Transplant Diagnostics
8.3 Market Opportunities and Trends
8.3.1 Emergence of cfDNA in Transplant Diagnostics
8.3.2 Growing Demand for Transplant Diagnostics in Emerging Economies
8.3.3 Increasing Focus on Identifying Novel Biomarkers for Minimizing Transplantation Rejection
9 Global Transplant Diagnostics Market
9.1 Market Overview
9.2 Market Size & Forecast
9.3 Five Forces Analysis
10 By Products
10.1 Market Snapshot & Growth Engine
10.2 Market Overview
10.3 Consumables & Test Kits
10.4 Instruments & Software
11 By Applications
11.1 Market Snapshot & Growth Engine
11.2 Market Overview
11.3 Diagnostic Applications
11.4 Research Applications
12 By Technology
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
12.3 Molecular Tests
12.4 Non-molecular
13 By Transplantation
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Solid Organ Transplantation
13.4 Soft Tissue Transplantation
14 By End-Users
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Standard Reference Laboratories
14.4 Hospitals & Transplant Centers
14.5 Academic Institutes & Research Laboratories
15 By Geography
15.1 Market Snapshot & Growth Engine
15.2 Overview
16 North America
16.1 Market Overview
16.2 Market Size & Forecast
16.3 Key Countries
16.3.1 US: Market Size & Forecast
16.3.2 Canada: Market Size & Forecast
17 Europe
18 APAC
19 Latin America
20 Middle East & Africa
21 Competitive Landscape
21.1 Competition Overview
21.2 Market Share Analysis
21.2.1 Thermo Fisher Scientific
21.2.2 F. Hoffmann-La Roche
21.2.3 bioMrieux
21.2.4 Bio-Rad Laboratories
21.2.5 Qiagen
21.2.6 Immucor
22 Key Company Profiles
22.1 Thermo Fisher Scientific
22.2 F. Hoffmann-La Roche
22.3 bioMrieux
22.4 Bio-Rad Laboratories
22.5 Qiagen
22.6 Immucor
23 Other Prominent Vendors
23.1 BAG Diagnostics
23.2 CareDx
23.3 ELITechGroup
23.4 Genome Diagnostics
23.5 Illumina
23.6 NanoString Technologies
23.7 Omixon
23.8 Transplant Genomics
23.9 Wakunaga Pharmaceutical
24 REPORT SUMMARY
24.1 Key Takeaways
24.2 Strategic Recommendations
24.3 Quantitative Summary
For more information about this report visit https://www.researchandmarkets.com/r/v245dk
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900